tirzepatide cause death The promise of tirzepatide: A narrative review of metabolic benefits Nurse's death linked to weight-loss
Description
are pregnant, breastfeeding or under 18 years
Clinical studies show average weight loss of 1520%, though results vary based on dosage, starting weight, and adherence
Highlights of prescribing information: Zepbound (tirzepatide) injection, for subcutaneous use
Calcium: defending your bones during weight loss Rapid weight loss increases bone turnover and fracture risk
May complement tirzepatide metabolic effects, though evidence for muscle preservation is limited
